drugset / Trial / NCT00844207
A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine
RandomizedParallel-groupOpen-labelHealth-services research
Summary
The primary objective is to estimate the relative bioavailability of fixed azithromycin / chloroquine combination tablets relative to co-administered individual tablets of azithromycin and chloroquine.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 500 mg | — |
| Comparator | Chloroquine | Small molecule | 300 mg | — |
| Comparator | Chloroquine | Small molecule | 310 mg | — |